Curis
CRIS
#10294
Rank
S$14.76 M
Marketcap
S$1.14
Share price
-1.39%
Change (1 day)
-74.31%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.67. In 2024 the company made an earnings per share (EPS) of S-$8.94 an increase over its 2023 EPS that were of S-$11.49.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-45.49%
2024S-$8.94-22.15%
2023S-$11.49-26.17%
2022S-$15.5622.3%
2021S-$12.72-25.37%
2020S-$17.05-30.93%
2019S-$24.68-2.02%
2018S-$25.19
2016S-$57.24-10%
2015S-$63.60138.1%
2014S-$26.7140%
2013S-$19.08-25%
2012S-$25.4466.67%
2011S-$15.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.19-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.78-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.03-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.30-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.30 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.79-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA